Upcoming Medical Conferences in SomervilleSearch Criteria : United States of America Somerville
Apr 04, 2020 | CME 7.50 | USD $250 | Somerville, Massachusetts
Practice Changing Updates in Hematology and Hematologic Malignancies is organized by Harvard Medical School (HMS) and will be held on Apr 04, 2020 at The Row Hotel at Assembly Row, Autograph Collection, Somerville, Massachusetts, United States of America. Target Audience: This course is targeted to specialty physicians, nurse practitioners, physician assistants and fellows/residents. This course may also be of interest to physicians who practice in oncology and hematology. Accreditation: Physicians: The Harvard Medical School designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Description: With several new drug therapies as well as an expansion of our understanding of the biologic heterogeneity of hematologic diseases, there is a need for education in the area of hematologic disorders. This interactive course will focus on current best practices, and how those are evolving based on major updates in the fields of benign hematology and hematologic malignancies. Attendee interaction is encouraged and promoted through the designated time after each presentation for audience questions and panel discussions with the speakers. This year we have updated the format to include breakout sessions designed for attendees to tailor their educational experience to their interest and needs. There is also a new topic to the course: “When Should I Refer My Patient for Transplant Evaluation?” Objectives: Upon completion of this activity, participants will be able to: • Manage complex coagulation and blood banking cases through knowledge of new treatment options • Evaluate new drugs and combination therapy for myeloma and lymphoid malignancies • Discuss new concepts in palliative care and survivorship • Determine appropriate timing to consider transplant evaluation for hematologic malignancies.
May 29 - 31, 2020 | CME 20.50 | USD $900 | Somerville, Massachusetts
Current Concepts in Hematopathology is organized by Harvard Medical School (HMS) and will be held from May 29 - 31, 2020 at Partners HealthCare Corporate Campus, Somerville, Massachusetts, United States of America. Target Audience: This course is targeted to Specialty Physicians who practice in Pathology. Accreditation: Physicians: The Harvard Medical School designates this live activity for a maximum of 20.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Self-Assessment Module (SAMs): This activity is approved for 20.50 credits of Lifelong Learning (Part II) and Self-Assessment Module (SAM) eligible credits towards the American Board of Pathology’s Maintenance of Certification Program. Description: This course will provide pathologists with a review of diagnostic issues encountered in clinical hematopathology practice, with a focus on challenging cases. Topics will include an in-depth discussion of microscopic evaluation of hematolymphoid disorders, as well as the appropriate use of a broad range of ancillary studies. The course will address (1) common pitfalls in the morphologic interpretation and immunophenotyping of hematolymphoid proliferations, (2) the approach to cases that do not conform to WHO diagnostic categories, and (3) the use of cytogenetics and molecular testing to inform the diagnosis, using evidence-based guidelines. We will also address important subject matter not covered in the prior course (May 2018), including plasma cell neoplasms, immunodeficiency and virus-associated lymphoproliferations, eosinophilias, mast cell disorders, assessment of treatment response, Hodgkin lymphomas, and IgG4-related disease. Material will be presented as lectures by leading experts in the field as well as interactive case-based presentations that illustrate common diagnostic pitfalls and underscore points made during the lectures. Objectives: Upon completion of this activity, participants will be able to: • Correctly use morphologic criteria and cost-effectively use ancillary studies to diagnose a broad range of lymph node and bone marrow pathologies. • Apply evidence-based criteria to the diagnosis of myeloid and lymphoid neoplasms. • Diagnose challenging cases that do not readily conform to 2017 WHO classification entities. • Evaluate and distinguish hematolymphoid malignancies from non-neoplastic mimics of malignancy.